Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03333044 · ClinicalTrials.gov registry record · NA
Diabetes Management Intervention For South Asians
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 859
- Enrollment target
NCT03333044: Completed NA study, sponsored by NYU Langone Health.
NCT03333044 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 859 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03333044, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 859 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the effectiveness and implementation process of a multi-level, integrated intervention to decrease HbA1c among South Asians with uncontrolled diabetes, including four components: 1) an EHR-based registry function to increase identification of South Asian patients with uncontrolled diabetes; 2) CHW-led health coaching of registered patients to promote health behavior change; 3) HIT-enabled and CHW-facilitated identification and referral to culturally relevant community resources for patients; and 4) HIT-enabled care coordination between the CHW and other members of the healthcare team.
Primary Outcome
Measured via complete lipoprotein panel.
Interventions
- BEHAVIORAL Community Health Worker (CHW)-Led Health Coaching
- OTHER EHR-Embedded Alerts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 859 participants |
| Start Date | 2019-07-11 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT03333044 record still lists
NCT03333044 is an interventional study that assigns participants to a tested intervention. The registered 859 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower).
The record links to 0 conditions, and to 2 interventions - of which Community Health Worker (CHW)-Led Health Coaching is the first listed.
NCT03333044 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03333044 about?
NCT03333044 is a clinical study titled "Diabetes Management Intervention For South Asians". The goal of this study is to evaluate the effectiveness and implementation process of a multi-level, integrated intervention to decrease HbA1c among South Asians with uncontrolled diabetes, including four components: 1) an EHR-based registry function to increase identification of South Asian patient...
What is the current status of trial NCT03333044?
This trial is currently completed. It is a NA study. The enrollment target is 859 participants. The study started on 2019-07-11. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT03333044?
The interventions under investigation include: Community Health Worker (CHW)-Led Health Coaching (BEHAVIORAL), EHR-Embedded Alerts (OTHER).
Who is sponsoring clinical trial NCT03333044?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03333044's enrollment target sits among peer trials
859 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04541381 · 860 participants · NA
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
- NCT05211895 · 860 participants · Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
- NCT06161025 · 860 participants · Phase 2
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- NCT06541574 · 860 participants · Phase 2
Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI